EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Substrate specificity controlled by the exit site of human P4-ATPases, revealed by de novo point mutations in neurological disorders

David C Calianese, Tomoyasu Noji iD, Jennifer A Sullivan, Kelly Schoch, Vandana Shashi, Vanda McNiven, Luiza Lorena Pires Ramos, Albena Jordanova, Judit Kárteszi, Hiroshi Ishikita iD, Shigekazu Nagata iD

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2415755121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von David C Calianese und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Immunology, World Premier International Research Center, Immunology Frontier Research Center, Osaka University, Suita,…. Hauptthemen laut MEDLINE: Point Mutation, Adenosine Triphosphatases, Nervous System Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Fonds Wetenschappelijk Onderzoek (FWO).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The maintenance of lipid asymmetry on the plasma membrane is regulated by flippases, such as ATP8A2, ATP11A, and ATP11C, which translocate phosphatidylserine and phosphatidylethanolamine from the outer leaflet to the inner leaflet. We previously identified a patient-derived point mutation (Q84E) in ATP11A at the phospholipid entry site, which acquired the ability to flip phosphatidylcholine (PtdCho). This mutation led to elevated levels of sphingomyelin (SM) in the outer leaflet of the plasma membrane. We herein present two de novo ATP11A dominant mutations (E114G and S399L) in heterozygous patients exhibiting neurological and developmental disorders. These mutations, situated near the predicted phospholipid exit site, similarly confer the ability for ATP11A to recognize PtdCho as a substrate, resulting in its internalization into cells. Cells expressing these mutants had increased SM levels on their surface, attributed to the up-regulated expression of the sphingomyelin synthase-1 gene, rendering them more susceptible to SM phosphodiesterase-mediated cell lysis. Corresponding mutations in ATP11C and ATP8A2, paralogs of ATP11A, exerted similar effects on PtdCho-flipping activity and increased SM levels on the cell surface. Molecular dynamics simulations, based on the ATP11C structure, suggest that the E114G and S399L mutations enhance ATP11C’s affinity toward PtdCho. These findings underscore the importance of the well-conserved exit and entry sites in determining phospholipid substrate specificity and indicate that aberrant flipping of PtdCho contributes to neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Point MutationAdenosine TriphosphatasesNervous System DiseasesHumansSubstrate SpecificityCell MembranePhosphatidylcholinesSphingomyelinsPhospholipid Transfer Proteins

Stichwörter der Autor:innen

flippaseneurological disorderplasma membranepoint mutationsphingomyelin

Substanzen

Adenosine TriphosphatasesPhosphatidylcholinesSphingomyelinsPhospholipid Transfer Proteins

Autor:innen und Institutionen

  • Laboratory of Biochemistry and Immunology, World Premier International Research Center, Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan.
  • Theoretical Chemistry, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo 153-8904, Japan.
  • Division of Medical Genetics, Department of Pediatrics, Duke University School of Medicine, Durham, NC 27705.
  • Fred A Litwin Family Centre in Genetic Medicine, University Health Network, Toronto, ON M5T 3L9, Canada.
  • Department of Pediatrics, McMaster Children's Hospital, Hamilton, ON L8N 3Z5, Canada.
  • Molecular Neurogenomics group, Vlaams Instituut voor Biotechnologie Center for Molecular Neurology, Vlaams Instituut voor Biotechnologie, Antwerp 2610, Belgium.

ORCID-Profile: Tomoyasu Noji, Hiroshi Ishikita, Shigekazu Nagata

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)
  • Fonds Wetenschappelijk Onderzoek (FWO)

Zitieren

APA

Calianese, D. C., Noji, T., Sullivan, J. A., Schoch, K., Shashi, V., McNiven, V., Ramos, L. L. P., Jordanova, A., Kárteszi, J., Ishikita, H., & Nagata, S. (2024). Substrate specificity controlled by the exit site of human P4-ATPases, revealed by de novo point mutations in neurological disorders. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2415755121

Vancouver

Calianese DC, Noji T, Sullivan JA, Schoch K, Shashi V, McNiven V, et al. Substrate specificity controlled by the exit site of human P4-ATPases, revealed by de novo point mutations in neurological disorders. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2415755121

BibTeX
@article{Calianese2024,
  author = {Calianese, David C and Noji, Tomoyasu and Sullivan, Jennifer A and Schoch, Kelly and Shashi, Vandana and McNiven, Vanda and Ramos, Luiza Lorena Pires and Jordanova, Albena and Kárteszi, Judit and Ishikita, Hiroshi and Nagata, Shigekazu},
  title = {Substrate specificity controlled by the exit site of human P4-ATPases, revealed by de novo point mutations in neurological disorders},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2415755121}
}
Kostenlos starten →